Related Experiment Video
Updated: Mar 21, 2026
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.7K
Medication management during electroconvulsant therapy
1Clinical Pharmacy and Practice, College of Pharmacy, Qatar University, Doha, Qatar.
Neuropsychiatric Disease and Treatment
|May 5, 2016
Summary
Electroconvulsive therapy (ECT) is a safe and effective treatment for psychiatric disorders. This review examines how medications used during ECT affect treatment outcomes and safety, offering guidance for pharmacotherapy decisions.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Electroconvulsive therapy (ECT) is a vital treatment for severe psychiatric conditions.
- Many patients undergoing ECT are concurrently using other medications.
- Understanding drug interactions is crucial for optimizing ECT efficacy and safety.
Purpose of the Study:
- To review recent literature on medications used during ECT procedures.
- To analyze the impact of concurrent medications on ECT effectiveness and safety.
- To provide evidence-based recommendations for pharmacotherapy management in ECT patients.
Main Methods:
- Extensive literature search of electronic databases.
- Keywords included "ECT" and "medications" or "drug classes".
- Focus on recent publications and existing guideline documents.
Main Results:
- Concurrent medications can influence ECT outcomes and safety profiles.
- Specific drug classes require careful consideration during ECT.
- Literature review provides insights into managing polypharmacy in ECT.
Conclusions:
- Pharmacotherapy decisions for ECT patients require careful evaluation of drug interactions.
- Optimizing medication regimens can enhance ECT effectiveness and patient safety.
- Further research is needed to refine guidelines for concurrent medication use in ECT.
Related Concept Videos
01:30Electroconvulsive Therapy
1.9K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.9K
01:24Mania and Antimanic Drugs: Overview
747
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
747
01:26Psychosis: Goals of Pharmacotherapy
656
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
656
01:20Antiepileptic Drugs: Potassium Channel Activators
913
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
913
01:28Drug Therapy
387
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
387
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K